Patent US2330827A successfully refreshed from Google Patents.
US4128641A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Tetracyclic psychotropic drug
Assignee: Hzi Research Center
•
Filing: 1977-02-28
•
Granted: 1978-12-05
•
Expires: 1997-02-28
Abstract
Abstract A method of treating patients having a psychiatric condition such as schizophrenia, or having an anxiety syndrome or other neurosis, comprising administering to such patient a therapeutically effective amount of a compound having the formula ##STR1##
Inventors
- 👤 Turan M. Itil
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 21:54
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
31 words
A method of treating psychiatric patients exhibiting psychotic behavior, and in particular a schizophrenic symdrome which comprises administering to such patient a therapeutically-effective amount of a compound having the formula ##STR3##
Claim 2
Independent Claim
31 words
A method of treating psychiatric patients exhibiting psychotic behavior, and in particular a schizophrenic symdrome which comprises administering to such patient a therapeutically-effective amount of a compound having the formula ##STR3##
Claim 3
Independent Claim
35 words
A method of treating psychiatric patients exhibiting symptoms of anxiety, particularly when associated with neurotic or neurasthenic disorders comprising administering to such patient a therapeutically effective amount of a compound having the following formula ##STR4##
Claim 4
Independent Claim
35 words
A method of treating psychiatric patients exhibiting symptoms of anxiety, particularly when associated with neurotic or neurasthenic disorders comprising administering to such patient a therapeutically effective amount of a compound having the following formula ##STR4##
Claim 5
Dependent Claim
19 words
A method as defined in claim 1, wherein said compound is administered in amounts of about 5-300 mg daily.
Claim 6
Dependent Claim
19 words
A method as defined in claim 2, wherein said compound is administered in amount of about 5-50 mg daily.
Claim 7
Dependent Claim
13 words
A method as defined in claim 1, wherein said compound is administered orally.
Claim 8
Dependent Claim
16 words
A method as defined in claim 1, wherein said compound is administered orally in tablet form.
Claim 9
Dependent Claim
27 words
A method as defined in claim 1, wherein said compound is administered orally in form of its solution, suspension or dispersion, in a suitable pharmaceutical liquid vehicle.
Claim 10
Dependent Claim
25 words
A method as defined in claim 1, wherein said compound is in the form of a tablet, capsule, pellet, dragee, pill, powder or granular substance.
Claim 11
Dependent Claim
19 words
A method as defined in claim 1, wherein said compound is administered parenterally in the form of injectable solution.
Claim 12
Dependent Claim
15 words
A method as defined in claim 1, wherein said compound is administered in long-acting form.
References Cited (Backward Citations)
US3534041A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-12-04 | 1982-06-05 | 1982-12-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-12-04 | 1986-06-05 | 1986-12-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-12-04 | 1990-06-05 | 1990-12-05 | $7700.00 | Window Closed / Lapsed |